Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: J05AP09

Exviera(dasabuvir sodium)

Hepatitis C, Chronic

Marketing Authorisation Holder: AbbVie Ltd

EMA Authorisation: 14/01/2015

INN: dasabuvir

Indication

Exviera is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults. For hepatitis C virus (HCV) genotype specific activity.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Exviera — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.